3-(2,2,2-trimethylhydrazine)propionate has been researched along with phosphocreatine in 1 studies
Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (phosphocreatine) | Trials (phosphocreatine) | Recent Studies (post-2010) (phosphocreatine) |
---|---|---|---|---|---|
251 | 35 | 105 | 7,475 | 329 | 575 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abiko, Y; Akahira, M; Hara, A | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and phosphocreatine
Article | Year |
---|---|
Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Administration, Oral; Animals; gamma-Butyrobetaine Dioxygenase; Heart; Hydrogen Peroxide; Male; Methylhydrazines; Mixed Function Oxygenases; Phosphocreatine; Rats; Rats, Sprague-Dawley; Ventricular Function | 1997 |